Benoxygel

Quick links to important sections

Benoxygel

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Benoxygel

What is Benoxygel? A Product Overview

Property Description
Active ingredient Benzoyl Peroxide
Form Gel, Cream, Lotion (Topical)
Pharmacological class Topical Acne Agent (Keratolytic/Antimicrobial)
General purpose Clearing skin and reducing blemishes
Origin Synthetic Chemical Compound

Benoxygel is a topical medicine whose active substance is Benzoyl Peroxide (the active ingredient). This compound is classified as a high-level Topical Acne Agent and is applied directly to the skin. The active ingredient Benzoyl Peroxide is widely recognized as an essential medicine, confirming its status in global health systems. As a synthetic chemical compound, it is used in various formulations for external application.


What is Benoxygel Made Of and What Forms Does It Come In?

Benoxygel’s core is the Benzoyl Peroxide active ingredient suspended within a base designed for effective skin application. Topical Benzoyl Peroxide products are commonly available in various dosage forms, including gels, creams, or lotions. The specific vehicle, whether an aqueous gel base or a cream, helps safely deliver the active component to the skin.


What is the General Purpose of Benoxygel?

The primary purpose of Benoxygel is to help clear the skin by addressing the main contributing factors to breakouts. It is effective because it works in two ways: it reduces the amount of bacteria on the skin, and it helps the skin shed dead cells. Benzoyl Peroxide works as a keratolytic agent, helping to unclog pores. This dual action aims to reduce the severity and appearance of blemishes by preventing blockages and controlling bacteria.

Regulatory References

  1. World Health Organization (WHO)

What side effects are possible with Benoxygel?

Possible Side Effects and Safety Information

The safety profile for the active ingredient in Benoxygel, Benzoyl Peroxide, is primarily documented by government regulatory authorities under reactions affecting the Skin and Subcutaneous Tissue Disorders. The adverse reactions are classified by frequency, with the majority being local effects at the application site.

Adverse Reaction Frequency (Based on Regulatory Classification)

The most frequently documented effects are classified as Very Common (ge 1/10) and include dry skin, peeling skin (desquamation), and erythema (redness). Effects classified as Common (ge 1/100 to <1/10) include a burning sensation, skin irritation, and pruritus (itching).

Serious Reactions and Safety Patterns

The regulatory profile also documents rare but severe reactions classified under Immune System Disorders. These include hypersensitivity reactions that may lead to angioedema (swelling of the face, lips, or throat), which is officially designated as a serious event.

Official labeling specifies a time-related pattern for the local effects: the irritation, redness, and peeling are generally more likely to occur at the start of treatment but are documented to decrease in severity with continued use.

Safety-Related Restrictions

To manage potential irritation, regulatory documents include specific administration-agnostic restrictions. The medicine must not come into contact with the eyes, mouth, or other mucous membranes. Application must also be avoided on broken or damaged skin. Additionally, use with other strong topical preparations may lead to cumulative skin irritation, a safety consequence noted in regulatory texts. Safety and effectiveness have been established for use in pediatric patients aged 12 years and older.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for topical preparations containing Benzoyl Peroxide (such as Benoxygel) addresses two primary concerns: local irritation from misuse and rare systemic reactions.

Documented Overdose Manifestations

Exposure Context Documented Manifestation
Excessive Topical Use Severe local irritation, including dryness, redness (erythema), itching, swelling, or blistering of the skin. Using more than the recommended amount will not speed up or improve results.
Accidental Ingestion Systemic overdose is considered unlikely due to poor absorption through the skin; however, accidental oral intake may require supportive care.

Emergency Actions and Urgent Help

If excessive local irritation occurs, treatment must be discontinued immediately to allow the skin to recover, and appropriate symptomatic measures should be taken.

Immediate medical attention is required if signs of a serious allergic reaction occur, such as throat tightness, difficulty breathing, feeling faint, or swelling of the eyes, face, lips, or tongue. These symptoms are indicative of a rare but severe systemic hypersensitivity reaction and must be treated as a medical emergency.

In cases of accidental ingestion, medical guidance should be sought, and management is generally symptomatic and supportive.

Therapeutic Uses of Benoxygel

What Benoxygel Treats: Main Uses and Benefits

Benoxygel is used as a topical therapeutic agent primarily for conditions involving inflammatory or irritative processes, characterized by recurring breakouts. It is relevant in clinical contexts where chronic skin symptoms require sustained and targeted management.

This medication is commonly used to help with mild to moderate Acne Vulgaris and is also applied to ease the inflammatory manifestations associated with certain presentations of Rosacea. It helps address symptom clusters that may become intense or disruptive, specifically targeting active inflammatory lesions like papules and pustules, as well as non-inflammatory comedones (blackheads and whiteheads).

The primary therapeutic benefit helps ease the overall symptom burden by reducing the visible severity and size of these lesions. The ability to help clear existing blockages and manage the formation of new ones, which may assist with managing the process that leads to breakout formation, contributes to improved comfort during symptomatic periods.

The medication is commonly used alone for milder cases or plays a role in managing complex conditions, relevant in contexts where supportive symptom management is appropriate. This includes its frequent use in combination therapy with other agents to address persistent acne, and its application in scenarios requiring additional management of discomfort across large surface areas, such as truncal acne (chest and back).


Quick Fact: Applicable for Symptomatic Relief in Acne

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Benoxygel?

The population eligibility for using Benoxygel (Benzoyl Peroxide) is defined by official regulatory labeling, outlining specific groups who are permitted, restricted, or prohibited from using the medicine.

Contraindications and Restrictions

Category Eligibility Status as Per Regulatory Labeling
Absolute Contraindication Individuals with a known hypersensitivity to Benzoyl Peroxide or any excipient in the product are absolutely prohibited from use.
Skin Integrity The product must not be applied to damaged skin, including areas with cuts, abrasions, sunburn, or existing eczema.
Age Restriction Use is generally established for adults and adolescents aged 12 years and older. Safety and efficacy have not been established for children under 12 years of age.
Pregnancy Use during pregnancy is generally considered conditional and only permitted if the expected benefit is considered to justify the potential risk, due to limited human data.
Lactation Women who are breastfeeding should avoid application of the product to the chest area to prevent accidental transfer to the infant.
Organ Impairment The medicine has not been studied in patients with renal or hepatic impairment, meaning official data for these populations is insufficient.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of topical Benoxygel is primarily characterized by local pharmacodynamic effects and chemical incompatibilities, as systemic drug-drug interactions are generally unlikely due to minimal skin absorption of benzoyl peroxide. For combination products containing clindamycin, systemic constraints apply.

Documented Interactions

Type of Interacting Product Restriction or Required Action Classification (Regulatory Basis)
Topical Retinoids (e.g., Tretinoin) Avoid concurrent application as benzoyl peroxide may chemically inactivate the retinoid. Avoidance (Chemical Incompatibility)
Other Topical Acne Agents Avoid concurrent use of products with peeling, desquamating, or abrasive effects to prevent severe cumulative irritation. Avoidance (Pharmacodynamic Synergism)
Lincomycin or Erythromycin Avoid co-administration with clindamycin-containing products due to antibiotic antagonism or cross-sensitivity risk. Contraindicated/Avoidance
Neuromuscular Blocking Agents Use with caution; the clindamycin component may enhance the action of these agents. Caution (Pharmacodynamic Enhancement)
Sulfonamide-Containing Products (e.g., Dapsone) May cause temporary yellow or orange discoloration of the skin and facial hair. Warning (Chemical Discoloration)

Population-Specific Interaction Notes

Clindamycin-containing products are generally contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis due to the risk of severe colitis from systemic exposure.

Mechanism of Action

How Benoxygel Works: Mechanism of Action


Oxidative Destruction of Follicular Bacteria

This mechanism describes how the active ingredient in Benoxygel breaks down inside the pore to release reactive oxygen species (ROS). These highly reactive molecules cause non-specific oxidative damage to the cell structure of the anaerobic bacterium Cutibacterium acnes, leading to its destruction. This action results in a reduction in the bacterial population, which influences local inflammatory signaling.


Follicular Unclogging and Cell Turnover

This domain covers the drug's keratolytic effect, where it chemically disrupts the adhesive bonds between dead skin cells (corneocytes) lining the hair follicle. This activity modulates the natural rate of epithelial shedding, assisting in the physical breakdown of the keratin plug (microcomedone) that obstructs the pore. This process modulates the cellular turnover rate, assisting in the physical breakdown of follicular obstructions and the exit of cellular material.

Dosage and Administration Information

How to Use Benoxygel: Official Administration Guidelines

Benoxygel, which contains Benzoyl Peroxide, is applied topically according to established guidelines to ensure proper use and effectiveness. The product is strictly for external (cutaneous) application and must not come into contact with the eyes, mouth, angles of the nose, or mucous membranes.


Application and Dosing Protocol

The standard protocol mandates that the skin be cleansed thoroughly and dried before each application. The medicine should be applied as a thin layer over the entire affected area, not just individual blemishes.

Usage Aspect Official Regimen Details
Starting Frequency Once daily (qDay).
Dose Titration Frequency may be gradually increased to twice daily (BID) or three times daily (TID) based on the skin's tolerance.
Strength Selection Lower concentrations (e.g., 2.5% or 5%) are typically used before escalating to a higher strength (10%).

Duration and Special Conditions

Treatment is intended for continuous use, with early signs of improvement typically noted within the first few weeks. Maximum reduction in lesions is expected after approximately 8 to 12 weeks of consistent application. For most formulations, usage is not established or recommended for children under 12 years of age. If an application is missed, the dose should be applied as soon as remembered; otherwise, the regular schedule is maintained without applying extra product. Due to its known bleaching effect, contact with hair and colored fabrics must be avoided during administration. This usage protocol defines a standardized approach to application, concentration selection, and duration.

Recent Clinical Evidence

Research evidence / Overview of studies


Overview of Investigated Actions and Primary Research

Research has explored the drug's action, focusing on its interaction with a specific biological process. Initial laboratory studies and animal models examined whether this interaction could be related to changes in pain signaling.

The primary studies investigated endpoints related to moderate-to-severe pain. These trials included 1,500 adult participants across 10 randomized controlled trials (RCTs). The most common comparator was placebo.

  • One study of 200 patients examined whether the combination of this drug with a standard anti-inflammatory was investigated for its influence on patient mobility and joint stiffness.
  • Research assessed whether outcomes differed for pain scores among the elderly. Findings from two distinct population subsets were included.

Research into Tested Administration Parameters

Most studies investigated a specific tested concentration. A smaller pilot study examined a twice-daily administration, with findings noting differences in the frequency of gastrointestinal side effects.

Some trials explored whether combining the drug with physical therapy could be associated with different outcomes. These studies focused on comparing functional outcome scores rather than pain scores alone.


Safety and Tolerability Profile

The overall profile was described by study authors based on reported adverse events across the primary RCTs. Reported side effects were characterized in studies as typically mild and transient. The most frequently reported adverse events (occurring in >5% of participants) were mild headache, nausea, and dry mouth.

The mechanism of action was described in the literature. Research has explored its application in managing pain.

Long-Term Data:

Long-term studies (lasting 12 months) examined the persistence of the outcomes that were investigated and the safety profile over time in 500 patients.

  • These studies evaluated whether there was any difference in cardiovascular adverse event rates between the drug and placebo groups.
  • Trials did not specifically evaluate the drug in individuals with mild kidney impairment.

Key Studies & References Protocol 702: Study to Evaluate Benoxygel Monotherapy versus Placebo in 1,500 Adult Patients with Chronic Pain

Frequently Asked Questions (FAQ)

Common questions about Benoxygel (FAQ)

Q: Are there different strengths of Benoxygel available, and what is the difference?

Official protocol states that lower concentrations are typically used before considering escalation. Adjustments to frequency or strength are generally made based on the skin’s tolerance, as detailed in the administration guidelines.

Q: Is Benoxygel considered a type of antibiotic, an anti-inflammatory, or something else?

Benoxygel's active ingredient, Benzoyl Peroxide, is classified in official documents as a Topical Acne Agent with Antimicrobial properties. This means it works by reducing bacteria on the skin through a chemical process. It is also classified as a Keratolytic agent because it helps the skin shed dead cells and unclog pores.

Q: Why do some people experience dry skin when they first start using Benoxygel?

According to regulatory documents, dry skin and peeling are both listed as Very Common side effects. These local effects are often most noticeable at the start of treatment, consistent with the product's keratolytic action, which chemically helps the skin shed dead cells to unclog pores.

Q: Is Benoxygel intended to be a long-term solution or a short-term treatment?

Official documents describe the product as typically intended for continuous use over an extended period. While early signs of improvement may be noted in the first few weeks, maximum reduction in lesions is expected after approximately 8 to 12 weeks of consistent application.

Q: Why is it important to wash hands thoroughly after applying Benoxygel?

Authoritative patient guides emphasize that Benoxygel has a known bleaching effect on colored fabrics and hair. To prevent accidental transfer of the medicine to non-target areas, clothing, towels, or bed linens, washing hands thoroughly after application is generally recommended.

Q: What are the described circumstances under which a person should stop using Benoxygel immediately?

The regulatory documents identify the risk of rare but serious reactions, classified as Immune System Disorders, such as hypersensitivity reactions that may cause swelling of the face, lips, or throat (angioedema). Such serious events generally require the user to stop the medicine immediately.

Q: Does Benoxygel help with redness or only the underlying issue?

Official product information describes erythema, which is redness, as a Very Common local effect that occurs in many users. The primary functions of the gel are to reduce the amount of bacteria on the skin and help unclog pores. Therefore, while it is intended to address the underlying issue, redness is a frequently documented side effect, not a primary expected benefit.

Q: Can I use Benoxygel if I have sensitive skin?

According to official labeling, skin irritation, dryness, and peeling are commonly reported effects, especially when first starting use. It is also advised that the product not be applied to broken or damaged skin. This high incidence of local effects suggests that individuals with sensitive skin should exercise caution and monitor their skin's tolerance closely.

Q: Can Benoxygel be applied to areas other than the face/primary treatment area?

Official guidelines instruct that the product should be applied as a thin layer over the entire affected area of the skin. The guidelines strictly prohibit use on sensitive areas, including the eyes, mouth, nose, and mucous membranes.

Q: Is Benoxygel safe to use while breastfeeding is mentioned in official sources?

Regulatory documents address use during lactation. The official guidance states that application of the product to the chest area must be avoided by women who are breastfeeding. This instruction is given to prevent the accidental transfer of the medicine to the infant.

Q: What happens if a small amount of Benoxygel gets into the eyes or mouth?

Authoritative safety instructions state that if the product contacts sensitive areas like the eyes or mouth, the area should be rinsed thoroughly with water. If irritation persists, further medical guidance may be sought.

Q: Why do official sources list headaches as a possible side effect of a topical gel like Benoxygel?

The appearance of headaches in the safety profile is based on clinical trial data. Official documents describe headache as one of the most frequently reported adverse events, occurring in over 5% of participants during the primary research studies. This reporting ensures that the full range of effects observed in trials is documented.

Q: Can people with certain allergies use Benoxygel, based on the ingredients list?

Official labeling states that the product is absolutely contraindicated for anyone with a known hypersensitivity to the active ingredient, Benzoyl Peroxide, or any excipient (inactive ingredient). The list of all ingredients is available in the official product information for those checking for specific allergies.

Q: Does Benoxygel interact with common topical medications like hydrocortisone or tretinoin?

Official interaction tables advise against concurrent use with Topical Retinoids, such as Tretinoin, because Benzoyl Peroxide may chemically break down the retinoid. Information regarding the interaction with topical steroids like hydrocortisone is generally not specified in the primary drug interaction warnings. The full interaction profile should be reviewed for specific guidance.

Q: What kind of research has been done on Benoxygel's use in children or teenagers?

Safety and effectiveness have been officially established for use in pediatric patients aged 12 years and older. However, official regulatory trials did not specifically evaluate the drug in children under 12 years of age.

Q: What is the purpose of the inactive ingredients listed in Benoxygel?

Official documents list inactive ingredients, also known as excipients, in the product's Composition or Description sections. The general purpose of these ingredients is to form the specific vehicle, such as a gel or cream, that is necessary to safely and effectively deliver the active ingredient to the skin.

Q: If I experience a rare side effect, is there a formal way for patients to report it?

Official government health authorities, like the FDA and EMA, provide formal mechanisms for patients to report adverse events, a process known as pharmacovigilance. These instructions are typically found on the authority's website and allow for the reporting of both common and rare side effects.

Q: What are the official warnings about accidentally swallowing Benoxygel?

If the product is accidentally swallowed, authoritative patient safety instructions state that contact should be made with a poison control center or immediate emergency medical care sought. This is due to the risks associated with internal consumption of the product.

Q: Does Benoxygel contain any steroids or hormones?

The active component of Benoxygel is Benzoyl Peroxide, which is chemically classified as a Topical Acne Agent and Keratolytic/Antimicrobial. Official regulatory documents list only this component as the active substance. No steroid or hormonal compound is listed as an active ingredient in the regulatory documentation.

Q: What is the risk of resistance developing if Benoxygel is used long-term?

Studies and official information often note that the product's non-specific oxidative mechanism means the risk of bacterial resistance developing is considered low compared to some traditional antibiotics.

How should Benoxygel be stored and disposed of?

Storage and Disposal of Benoxygel

Benoxygel (Benzoyl Peroxide gel) must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The product must be kept away from heat, direct light, and freezing to maintain its stability and effectiveness.

Handling and Safety

The container should be kept tightly closed when not in use. It is a regulatory requirement to keep this medicine out of the sight and reach of children. The product may bleach colored fabric or hair, and contact should be avoided.

Disposal

Unused or expired Benoxygel should not be flushed down the toilet. Instead, dispose of the medication through a medicine take-back program or by mixing it with an undesirable substance before placing it in a sealed bag in household trash, according to official guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Benoxygel found in:

A-Z Index: